Key result
Korean lipid screening reveals ~4% meet NCEP ATP II criteria for drug therapy.
Cross-Sectional (n=69,563)
Answers are grounded in this paper and cite their sources.
Coronary heart disease is the most severe form of disease caused by atherosclerosis; and there is a strong relationship between serum lipid concentrations and atherosclerosis. By decade of life, means, standard deviations and selected percentiles were calculated according to sex for serum concentrations of total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglyceride in 69,563 Koreans. The prevalence of dyslipoproteinemias which were related to high risk of coronary heart disease were assessed. The mean concentrations of serum total cholesterol and LDL-C in the Korean population were 5.02 mmol/l and 3.00 mmol/l. The 75th and 90th percentile concentrations of total cholesterol were 5.59 mmol/l and 6.24 mmol/l. The mean concentrations of serum triglyceride and HDL-C were 1.58 mmol/l and 1.30 mmol/l. The hyperlipoproteinemia type IV (4.8%) was the most frequent, followed by Type IIa (4.6%), hypoalphalipoproteinemia (3.3%), and type IIb (0.2%). According to the National Cholesterol Education Program Adult Treatment Panel II, 4.1% of Korean adults needed the initial drug therapy and 10.8% the initial dietary therapy for hypercholesterolemia. The age and sex-specific treatment guidelines for hypercholesterolemia would make it possible that early intervention could be applied to atherosclerosis in Korean adults.
No takes yet. Share an insight, caveat, or question.
Chun et al. (1999) conducted a cross-sectional in Dyslipoproteinemia and coronary heart disease risk (n=69,563). Serum lipid concentrations (TC, LDL-C, HDL-C, TG) was evaluated on Distribution of serum lipid concentrations and prevalence of dyslipoproteinemias. Serum lipid assessment in 69,563 Koreans showed mean total cholesterol of 5.02 mmol/l and LDL-C of 3.00 mmol/l, with 4.1% needing drug therapy and 10.8% needing dietary therapy per NCEP ATP II.
Synapse has enriched 10 related papers. Consider them for comparative context: